Autologous Fat Transfer in Lupus Panniculitis Facial Lipoatrophy
Issued Date
2022-07-01
Resource Type
ISSN
22346163
eISSN
22346171
Scopus ID
2-s2.0-85135611561
Journal Title
Archives of Plastic Surgery
Volume
49
Issue
4
Start Page
527
End Page
530
Rights Holder(s)
SCOPUS
Bibliographic Citation
Archives of Plastic Surgery Vol.49 No.4 (2022) , 527-530
Suggested Citation
Kongkunnavat N., Prathyajuta J., Tonaree W. Autologous Fat Transfer in Lupus Panniculitis Facial Lipoatrophy. Archives of Plastic Surgery Vol.49 No.4 (2022) , 527-530. 530. doi:10.1055/s-0042-1751024 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/85734
Title
Autologous Fat Transfer in Lupus Panniculitis Facial Lipoatrophy
Author(s)
Author's Affiliation
Other Contributor(s)
Abstract
Lupus panniculitis (LP) often presents with tender nodules and intermittent ulcers that then heal with scarring and lipoatrophy. The current mainstay of treatment is medical treatment. Research regarding the treatment of lipoatrophy from LP with autologous fat grafting is limited. We would like to share our experience in this rare case, which was treated with autologous fat transfer. A 48-year-old female presented with erythematous plaque, tender nodules, and ulcers following by a depression of the lesion at the left temporal area. The patient also had indurated erythematous plaque at her left cheek. Both lesions were aggravated by sunlight exposure. After several investigations, she was diagnosed as LP with secondary lipoatrophy and tumid lupus erythematosus at her left temporal and left cheek, respectively. She received antimalarial drug and topical steroids. The patient underwent two sessions of autologous fat transfer. She was satisfied with the volume and contour improvement in the scar following the injection of 8 and 3.7 mL of fat. Furthermore, the patient reported the remission of tender nodules and ulcers since the first fat graft injection. In conclusion, the autologous fat transfer is a simple and effective treatment for lipoatrophy and scar secondary to LP with promising results.